Central injections of nocistatin or its C‐terminal hexapeptide exert anxiogenic‐like effect on behaviour of mice in the plus‐maze test

No abstract is available for this paper.

• Publication year

  2002

• Venue

  British Journal of Pharmacology

• Publication date

  2002-07-01

• Fields of study

  Biology, Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1038/sj.bjp.0704739PMID 12086986PMCID PMC1573391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of a plus-maze to measure anxiety in the mouse

  2004cited by this paper
• Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (ppOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities.

  2001cited by this paper
• Endogenous nociceptin signaling and stress-induced analgesia

  2001cited by this paper
• Altered Processing of Pro-Orphanin FQ/Nociceptin and Pro-Opiomelanocortin-Derived Peptides in the Brains of Mice Expressing Defective Prohormone Convertase 2

  2001cited by this paper
• Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice

  2001cited by this paper
• Inhibitory action of nociceptin/orphanin FQ on functionally different thalamic neurons in urethane‐anaesthetized rats

  2001cited by this paper
• Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ.

  2000cited by this paper
• Nocistatin inhibits food intake in rats.

  2000cited by this paper
• Pharmacology of nociceptin and its receptor: a novel therapeutic target

  2000cited by this paper
• A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.

  2000cited by this paper
• Ethological confirmatory factor analysis of anxiety-like behaviour in the murine elevated plus-maze.

  2000cited by this paper
• The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1‐13)NH2, potentiates morphine analgesia

  2000cited by this paper
• Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor.

  2000cited by this paper
• Functional studies using antibodies against orphanin FQ/nociceptin.

  2000cited by this paper
• The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice.

  2000cited by this paper
• Identification of human, rat and mouse nocistatin in brain and human cerebrospinal fluid

  1999cited by this paper
• Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice.

  1999cited by this paper
• Opioid receptor‐like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with 125I‐[14Tyr]‐orphanin FQ binding

  1999cited by this paper
• Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord.

  1999cited by this paper
• Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat

  1999cited by this paper
• Effect of nociceptin on alcohol intake in alcohol-preferring rats

  1999cited by this paper
• Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system.

  1999cited by this paper
• Effect of nocistatin and its interaction with nociceptin/orphanin FQ on the rat formalin test.

  1999cited by this paper
• Intracerebroventricular administration of nocistatin reduces inflammatory hyperalgesia in rats.

  1999cited by this paper
• Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice.

  1999cited by this paper
• Nocistatin reverses the effect of orphanin FQ/nociceptin in antagonizing morphine analgesia.

  1999cited by this paper
• Nociceptin‐induced scratching, biting and licking in mice: involvement of spinal NK1 receptors

  1999cited by this paper
• Identification of human, rat and mouse nocistatin in brain and human nocistatin in brain and human cerebrospinal fluid.

  1999cited by this paper
• Orphanin FQ/nociceptin blocks acquisition of morphine place preference.

  1999cited by this paper
• Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice.

  1998cited by this paper
• Pain: nocistatin spells relief.

  1998cited by this paper
• Nocistatin, a peptide that blocks nociceptin action in pain transmission

  1998influential reference
• Naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice.

  1998cited by this paper
• Neuronal nitric oxide synthase is permanently decreased in the cerebellum of rats subjected to chronic neonatal blockade of N-methyl-D-aspartate receptors.

  1998cited by this paper
• Orphanin FQ is the major OFQ1-17-containing peptide produced in the rodent and monkey hypothalamus.

  1998cited by this paper
• Nocistatin reverses nociceptin inhibition of glutamate release from rat brain slices.

  1998cited by this paper
• Anxiety, defence and the elevated plus-maze.

  1997cited by this paper
• Orphan neuropeptide NocII, a putative pronociceptin maturation product, stimulates locomotion in mice

  1997cited by this paper
• Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress.

  1997cited by this paper
• Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test

  1997cited by this paper
• Nociceptin/Orphanin FQ Microinjected into Hippocampus Impairs Spatial Learning in Rats

  1997cited by this paper
• Orphanin FQ acts as a supraspinal, but not a spinal, anti‐opioid peptide

  1996cited by this paper
• Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ

  1996cited by this paper
• Nociceptin stimulates locomotion and exploratory behaviour in mice.

  1996cited by this paper
• Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: its involvement in allodynic response to innocuous stimulus.

  1996cited by this paper
• Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ.

  1996cited by this paper
• Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats

  1996cited by this paper
• Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene.

  1996cited by this paper
• Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

  1996cited by this paper
• Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor

  1995cited by this paper
• Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

  1995cited by this paper
• Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol

  1994cited by this paper
• Intracerebroventricular injections in mice. Some methodological refinements.

  1986cited by this paper
• Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

  1957cited by this paper

• Drug repurposing opportunities for breast cancer and seven common subtypes.

  2024cites this paper
• Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release

  2023cites this paper
• Rostromedial tegmental nucleus nociceptin/orphanin FQ (N/OFQ) signaling regulates anxiety- and depression-like behaviors in alcohol withdrawn rats

  2022cites this paper
• The Role of Nociceptin in Opioid Regulation of Brain Functions

  2021cites this paper
• Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders

  2021cites this paper
• Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System

  2019cites this paper
• Endogenous Neuropeptide Nocistatin Is a Direct Agonist of Acid-Sensing Ion Channels (ASIC1, ASIC2 and ASIC3)

  2019cites this paper
• Modulation of the NOP receptor signaling affects resilience to acute stress

  2019cites this paper
• NOP Ligands for the Treatment of Anxiety and Mood Disorders.

  2018cites this paper
• nociceptin/orphanin FQ melanin-concentrating hormone neurons by GIRK channel-mediated inhibition of

  2015cites this paper
• Pain regulation by nocistatin-targeting molecules: G protein-coupled-receptor and nocistatin-interacting protein.

  2015cites this paper
• Nocistatin: milestone of one decade of research.

  2014cites this paper
• Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system.

  2014cites this paper
• Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task

  2014cites this paper
• The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.

  2014cites this paper
• The use of bifunctional NOP/mu and NOP receptor selective compounds for the treatment of pain, drug abuse, and psychiatric disorders.

  2013cites this paper
• The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation

  2013cites this paper
• Deciphering intracellular localization and physiological role of nociceptin and nocistatin.

  2013cites this paper
• Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin.

  2013cites this paper
• Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.

  2013cites this paper
• Nocistatin and nociceptin modulate c-Fos expression in the mice thalamus

  2012cites this paper
• Identification of NIPSNAP1 as a Nocistatin-interacting Protein Involving Pain Transmission*

  2012cites this paper
• Effects of intraplantar nocistatin and (±)-J 113397 injections on nociceptive behavior in a rat model of inflammation.

  2012cites this paper
• Structural Requirements of N-Substituted Spiropiperidine Analogues as Agonists of Nociceptin/Orphanin FQ Receptor

  2011cites this paper
• Universidade Federal de Santa Catarina Centro de Ciências Biológicas Departamento de Farmacologia Programa de Pós-Graduação em Farmacologia

  2011cites this paper
• Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies.

  2011cites this paper
• GIRK channel-mediated inhibition of melanin-concentrating hormone neurons by nociceptin/orphanin FQ.

  2011cites this paper
• Nociceptin/orphanin FQ - NOP receptor system: novel genetic and pharmacological tools

  2011cites this paper
• Anxiolytic-like effect of central administration of NOP receptor antagonist UFP-101 in rats submitted to the elevated T-maze.

  2011cites this paper
• 3D-QSAR, homology modeling, and molecular docking studies on spiropiperidines analogues as agonists of nociceptin/orphanin FQ receptor.

  2010cites this paper
• Nocistatin excites rostral agranular insular cortex-periaqueductal gray projection neurons by enhancing transient receptor potential cation conductance via G(alphaq/11)-PLC-protein kinase C pathway.

  2010cites this paper
• Nociceptin/orphanin FQ receptor ligands : pharmacological studies

  2009cites this paper
• Discovery of 1‐[1‐(1‐Methylcyclooctyl)‐4‐piperidinyl]‐2‐[(3R)‐3‐piperidinyl]‐1H‐benzimidazole: Integrated Drug‐Design and Structure–Activity Relationships for Orally Potent, Metabolically Stable and Potential‐Risk Reduced Novel Non‐Peptide Nociceptin/Orphanin FQ Receptor Agonist as Antianxiety Drug

  2009cites this paper
• Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam.

  2009cites this paper
• Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress.

  2009cites this paper
• Nocistatin and nociceptin exert opposite effects on the excitability of central amygdala nucleus-periaqueductal gray projection neurons.

  2009cites this paper
• The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential

  2008cites this paper
• Chapter 4.1 Peptide receptor ligands to treat anxiety disorders

  2008cites this paper
• The orphanin FQ/nociceptin (OFQ/N) system.

  2008cites this paper
• GABA(A) signalling is involved in N/OFQ anxiolytic-like effects but not in nocistatin anxiogenic-like action as evaluated in the mouse elevated plus maze.

  2008cites this paper
• Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice

  2008cites this paper
• Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine.

  2008cites this paper
• Effects of nociceptin/orphanin FQ in the acquisition of contextual and tone fear conditioning in rats.

  2008cites this paper
• The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity.

  2007cites this paper
• Nocistatin inhibits 5‐hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways

  2007influential citation
• Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation.

  2007cites this paper
• Nocistatin attenuated the nociceptin induced c-Fos expression in the mouse hippocampus.

  2007cites this paper
• Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice.

  2007cites this paper
• The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.

  2007cites this paper
• Localization of nocistatin-binding sites in mice brain and spinal cord using a biotinylated nocistatin probe

  2007cites this paper
• Nocistatin and its derivatives antagonize the impairment of short-term acquisition induced by nociceptin.

  2007cites this paper
• Effects of social crowding on emotionality and expression of hippocampal nociceptin/orphanin FQ system transcripts in mice.

  2007cites this paper
• Supraspinal nocistatin and its amide derivative antagonize the hyperalgesic effects of nociceptin in mice.

  2006cites this paper
• Biochemical, functional and pharmacological characterization of novel hexapeptide ligands targeting nociceptin/orphanin FQ receptor, in vitro and in vivo studies

  2006cites this paper
• Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats.

  2006cites this paper
• The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.

  2006cites this paper
• Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands

  2006cites this paper
• Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species

  2005cites this paper
• Effect of supraspinal Nocistatin on Nociceptin/Orphanin FQ antagonism of selective opioid analgesia.

  2005cites this paper
• EFFECTS OF NOCICEPTIN/ORPHANIN FQ MICROINJECTIONS INTO THE AMYGDALA ON ANXIETY-RELATED BEHAVIORS AND HYPOTHALAMIC-PITUITARY-ADRENAL AXIS ACTIVATION

  2005cites this paper
• Nociceptin/Orphanin FQ Increases Anxiety-Related Behavior and Circulating Levels of Corticosterone During Neophobic Tests of Anxiety

  2004influential citation
• Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene.

  2003cites this paper
• The neurobiology and control of anxious states.

  2003cites this paper
• Endogenous opiates and behavior: 2002.

  2003cites this paper
• Nociceptin/Orphanin FQ: Actions within the Brain

  2003cites this paper
• Chapter III Neuroanatomical studies of the opioid receptor-like-1 receptor and its endogenous neuropeptide orphanin FQ (nociceptin)

  2002cites this paper